IOL CHEMICALS & PHARM. | BAL PHARMA | IOL CHEMICALS & PHARM./ BAL PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.3 | 44.9 | 29.7% | View Chart |
P/BV | x | 1.5 | 2.5 | 61.0% | View Chart |
Dividend Yield | % | 1.0 | 1.0 | 103.0% |
IOL CHEMICALS & PHARM. BAL PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
BAL PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ BAL PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 134 | 400.2% | |
Low | Rs | 272 | 63 | 429.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 193.9 | 194.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.7 | 1,419.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 7.5 | 421.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 1.00 | 400.0% | |
Avg Dividend yield | % | 1.0 | 1.0 | 97.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 40.7 | 631.7% | |
Shares outstanding (eoy) | m | 58.71 | 15.69 | 374.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.5 | 210.3% | |
Avg P/E ratio | x | 17.1 | 59.2 | 28.8% | |
P/CF ratio (eoy) | x | 12.8 | 13.2 | 97.2% | |
Price / Book Value ratio | x | 1.6 | 2.4 | 64.8% | |
Dividend payout | % | 16.9 | 59.9 | 28.2% | |
Avg Mkt Cap | Rs m | 23,743 | 1,549 | 1,532.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 553 | 304.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 3,042 | 728.8% | |
Other income | Rs m | 256 | 9 | 2,721.6% | |
Total revenues | Rs m | 22,427 | 3,052 | 734.9% | |
Gross profit | Rs m | 2,257 | 253 | 893.7% | |
Depreciation | Rs m | 462 | 91 | 505.7% | |
Interest | Rs m | 165 | 123 | 133.8% | |
Profit before tax | Rs m | 1,887 | 47 | 3,972.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 21 | 2,325.5% | |
Profit after tax | Rs m | 1,391 | 26 | 5,312.7% | |
Gross profit margin | % | 10.2 | 8.3 | 122.6% | |
Effective tax rate | % | 26.2 | 44.8 | 58.5% | |
Net profit margin | % | 6.3 | 0.9 | 728.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 2,282 | 423.7% | |
Current liabilities | Rs m | 5,025 | 2,093 | 240.1% | |
Net working cap to sales | % | 20.9 | 6.2 | 338.4% | |
Current ratio | x | 1.9 | 1.1 | 176.5% | |
Inventory Days | Days | 43 | 8 | 564.9% | |
Debtors Days | Days | 8 | 1,128 | 0.7% | |
Net fixed assets | Rs m | 11,017 | 829 | 1,329.8% | |
Share capital | Rs m | 587 | 157 | 374.2% | |
"Free" reserves | Rs m | 14,490 | 481 | 3,012.6% | |
Net worth | Rs m | 15,077 | 638 | 2,363.6% | |
Long term debt | Rs m | 0 | 305 | 0.0% | |
Total assets | Rs m | 20,684 | 3,110 | 665.1% | |
Interest coverage | x | 12.5 | 1.4 | 898.8% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.0 | 109.6% | |
Return on assets | % | 7.5 | 4.8 | 156.7% | |
Return on equity | % | 9.2 | 4.1 | 224.8% | |
Return on capital | % | 13.6 | 18.1 | 75.2% | |
Exports to sales | % | 26.7 | 66.4 | 40.3% | |
Imports to sales | % | 0 | 22.4 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 2,020 | 293.5% | |
Imports (cif) | Rs m | NA | 683 | 0.0% | |
Fx inflow | Rs m | 5,930 | 2,020 | 293.5% | |
Fx outflow | Rs m | 6,052 | 716 | 845.5% | |
Net fx | Rs m | -122 | 1,305 | -9.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -18 | -6,630.7% | |
From Investments | Rs m | -1,200 | -222 | 541.0% | |
From Financial Activity | Rs m | -41 | 244 | -16.8% | |
Net Cashflow | Rs m | -18 | 4 | -492.0% |
Indian Promoters | % | 48.2 | 47.1 | 102.3% | |
Foreign collaborators | % | 0.0 | 4.2 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.1 | 1,307.7% | |
FIIs | % | 1.4 | 0.1 | 1,076.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 48.8 | 106.2% | |
Shareholders | 130,003 | 14,772 | 880.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | BAL PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.54% | 0.93% | -1.23% |
1-Month | 7.66% | 4.67% | 1.07% |
1-Year | -1.73% | 42.14% | 50.86% |
3-Year CAGR | -11.66% | 18.39% | 14.38% |
5-Year CAGR | 15.36% | 7.06% | 19.01% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the BAL PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of BAL PHARMA the stake stands at 51.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of BAL PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
BAL PHARMA paid Rs 1.0, and its dividend payout ratio stood at 59.9%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of BAL PHARMA.
For a sector overview, read our pharmaceuticals sector report.
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.